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A 37-year-old woman experienced a witnessed generalized seizure in the Emergency Department 
three hours after ingesting approximately 1400 mg of fluoxetine in a suicide attempt. Although the 
majority of fluoxetine ingestions are benign, seizures may occur after large intentional overdoses.
[WestJEM. 2008;9:154-156.]
INTRODUCTION
Fluoxetine (Prozac, Eli Lilly and Company, 
Indianapolis IN) is a selective serotonin reuptake inhibitor 
(SSRI) commonly used to treat depression and for other 
psychiatric indications. The majority of fluoxetine overdoses 
result in a benign clinical course. The largest published case 
series of fluoxetine overdoses found that the most common 
effects were tachycardia, drowsiness, tremor, nausea, and 
vomiting, and concluded that such overdoses typically are 
“minimally toxic”.1 Despite this suggestion that only mild 
to moderate symptomatology is to be expected, seizures,2-8 
cardiac conduction abnormalities,8 and even fatalities9 have 
been associated with fluoxetine ingestions, although most of 
these cases involve co-ingested drugs or other confounding 
factors. We report the case of a witnessed, generalized 
seizure occurring three hours after a fluoxetine overdose in an 
otherwise healthy young woman.
CASE REPORT
A 37-year-old woman with a history of bulimia nervosa 
and depression ingested approximately seventy 20 mg 
fluoxetine capsules and 4-5 cans of beer in a self-professed 
suicide attempt. Shortly thereafter, she telephoned a friend 
who activated the EMS system. The patient’s prescribed 
medications were fluoxetine 20 mg daily and buspirone 15 mg 
twice daily. The patient stated that she had taken her buspirone 
only as directed, with the last dose on the morning of the 
fluoxetine overdose, about six hours earlier. She specifically 
denied ingesting any additional buspirone or any other 
medications. She admitted to “purging” herself daily for the 
last week. Other than some orthopedic surgical procedures, 
she denied any other significant past medical history, 
including seizures.
The paramedics arrived approximately 90 minutes post-
ingestion and found the patient to be awake, alert, sitting up, 
and emotionally upset. The initial blood pressure was 142/
palp and cardiac monitoring showed a sinus tachycardia at 
120/minute. In the emergency department (ED) her vital 
signs were: temperature 37.2°C, pulse 91/min, blood pressure 
132/72 mmHg, respirations 20/min, O2 saturation 99% on 
room air. The emergency physician noted the patient to be 
alert and oriented, but with slurred speech and slow verbal 
response time. The patient had a non-focal neurologic exam 
without tremor, rigidity, or hyperreflexia, and the remainder 
of the physical examination was without noted abnormalities. 
The patient was given 50 g of activated charcoal, and 
blood and urine samples were obtained for baseline values 
and for quantitative serum acetaminophen and salicylate 
measurements. Serum chemistries showed sodium 138 
mmol/L, potassium 4.2 mmol/L, chloride 105 mmol/L, 
bicarbonate 23 mmol/L, BUN 11 mg/dL, creatinine 0.6 mg/
dL, glucose 81 mg/dL, salicylate 3.9 mg/dL, acetaminophen 
<1µg/mL, and ethanol 48 mg/dL. A qualitative urine 
pregnancy test was negative. An electrocardiogram revealed 
a normal sinus rhythm of 97 beats per minute with normal 
intervals (QRS 88 msec, QTc 461 msec).
Approximately three hours after the ingestion, the patient 
cried out and then experienced a generalized tonic-clonic 
seizure lasting 30 seconds witnessed by the ED personnel. 
The seizure resolved spontaneously, and the patient had a 
post-ictal period lasting five minutes. The patient received an 
intravenous loading dose of phenobarbital (620 mg [10mg/
kg]) and was then transported without incident to a regional 
toxicology referral center.
On arrival to the intensive care unit, the patient was 
somnolent but easily arousable. Vital signs were: temperature 
36.9°C, pulse 82/min, blood pressure 112/78 mmHg, 
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unremarkable including the neurologic exam. Additional 
laboratory data obtained upon admission included serum 
creatinine kinase (140 IU/L), calcium (8.8 mg/dL), and 
a comprehensive urine drug screen (which combines the 
enzyme-multiplied immunoassay technique, thin layer 
chromatography, and gas chromatography/mass spectroscopy 
to detect over 1500 drugs and metabolites) that showed 
the presence of only phenobarbital, fluoxetine, ethanol, 
and caffeine. The laboratory verified that buspirone can 
be detected by this analysis. Quantitative serum levels of 
fluoxetine, norfluoxetine, and buspirone were ordered on 
admission. The fluoxetine level six hours after the ingestion 
was 922 ng/mL (therapeutic = 50-480 ng/mL) and the 
norfluoxetine level was 379 ng/mL (therapeutic = 50-450 ng/
mL). The quantitative buspirone level could not be determined 
due to laboratory handling error. The patient was observed 
overnight without any further seizure activity or other unusual 
events. The psychiatry consultation and liaison service 
evaluated the patient the following morning and arranged for 
outpatient therapy. The patient was then discharged home in 
stable condition.
DISCUSSION
Data from human and animal trials show fluoxetine to be 
generally safe and with few drug interactions.10-12 Fluoxetine 
overdose typically results in a benign clinical course, with 
the most common symptoms being tachycardia, drowsiness, 
tremor, nausea, and vomiting, and has therefore been 
identified as “minimally toxic in doses up to 1,500 mg and 
with combined plasma levels [fluoxetine plus norfluoxetine] 
up to 1390 ng/mL.”1 With regard to potential neurotoxic 
effects, considerable evidence exists that fluoxetine has 
an anticonvulsant effect at therapeutic doses in humans 
and animal models.13 Antidepressants may display both 
anticonvulsant and pro-convulsant properties, with the 
most important determining factor being the dose.14 In a 
study of five different SSRIs taken in overdose, fluoxetine 
had the lowest incidence of inducing seizures (1%, vs. 
2% for sertraline, paroxetine, and citalopram, and 4% for 
fluvoxamine).15 Not surprisingly then, there are few reports of 
seizures associated with fluoxetine in the medical literature. 
Many of these reports are confounded by co-ingestants and/or 
underlying brain disease.2-5,8 Only a few cases of seizure after 
isolated fluoxetine overdose in normal subjects have been 
reported,6,7 and there is also a case occurring after escalation 
of therapeutic dosing up to 60 mg/day.16
Evidence in the patient presented here for an acute 
fluoxetine overdose is supported not only by history, but also 
from the relatively high ratio of the parent substance compared 
to norfluoxetine, its N-desmethylated metabolite. The seizure 
does not appear to be related to serotonin syndrome, because 
the patient did not exhibit autonomic instability, muscular 
rigidity, or abnormal mental status (excluding the seizure 
itself and a brief post-ictal period) as typically occur in that 
disorder.17 The patient also consumed some ethanol during her 
suicide attempt, but it is very unlikely that ethanol contributed 
to her seizure.  Firstly, she was only an occasional ethanol 
consumer without a history of dependence or prior episodes 
of withdrawal; in such a case, the presence of ethanol would, 
if anything, act as an anticonvulsant.  Secondly, she did not 
exhibit signs of autonomic instability (e.g., diaphoresis, 
hypertension) or tremor consistent with ethanol withdrawal.  
She was initially tachycardic, but this is also commonly found 
in cases of significant SSRI overdose.
Although acute fluoxetine overdose is believed to 
cause the seizure in this patient, buspirone might potentiate 
fluoxetine’s neurotoxicity. A seizure has been reported in a 
patient receiving therapeutic doses of fluoxetine and buspirone 
for obsessive-compulsive disorder.18 In contrast, a case series 
of 11 patients on fluoxetine and buspirone does not describe 
any seizures or other neurotoxicity.19 Caffeine overdoses 
have also been reported to cause seizures,20 and caffeine was 
detected in our patient’s urine. When questioned about this 
finding, she reported that she consumed caffeine-containing 
beverages (e.g. tea, soft drinks), but denied excessive 
use. Although a serum caffeine level is not available for 
this patient, she was not exhibiting symptoms of caffeine 
intoxication such as tremor, agitation, hyperglycemia or 
hypokalemia.20 She did have a mild tachycardia initially, but 
this spontaneously resolved prior to the seizure. In order for 
caffeine to be responsible for this seizure, one would expect 
the patient to exhibit prominent symptoms of caffeine toxicity. 
Thus, although the patient’s ingestion was not a completely 
isolated fluoxetine overdose, since other xenobiotics were 
detected, there is no evidence that any other drug contributed 
significantly to her seizure.
CONCLUSION
We report the clinical course of a patient who had a 
witnessed seizure following an acute fluoxetine overdose. 
While the medical literature strongly suggests that most 
fluoxetine overdoses are benign, emergency physicians need 
to remain cognizant that intentional, high-dose fluoxetine 
ingestions may induce seizures.
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